| Dr Javier J Rodriguez-becerra, MD | |
|
Urb Flamboyan, Calle Mckinley I 26, Manati, PR 00674-5438 | |
| (787) 854-7270 | |
| (787) 857-1737 |
| Full Name | Dr Javier J Rodriguez-becerra |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 24 Years |
| Location | Urb Flamboyan, Manati, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467413633 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 13598 (Puerto Rico) | Primary |
| Entity Name | Atlantic Pathology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336461128 PECOS PAC ID: 6406045053 Enrollment ID: O20110614000612 |
News Archive
Five Prime Therapeutics, Inc. today announced it received a milestone payment from Centocor Research & Development, Inc. for the selection of a therapeutic that will be pursued for immunology-related indications. Under the collaboration, FivePrime identified multiple potential therapeutic targets through screening its comprehensive proprietary protein library in cell-based assays that were focused on therapeutic pathways underlying specific immune and inflammatory disorders.
Eli Lilly and Company today announced it will begin enrolling patients in a second Phase III study of LY450139, a gamma-secretase inhibitor being investigated as a potential treatment to delay the progression of mild to moderate Alzheimer's disease.
The new decade may herald an era of cell therapy - treating human diseases by delivering highly specific beneficial cells. In the wake of an NIH decision late last year permitting federally funded researchers to use new lines of human embryonic stem cells, the door has opened more widely to stem cell research.
In the first published nationwide survey of state Medicaid programs on "pay-for-performance" practices, more than half of all programs state that they provide financial incentives to health care providers for better quality care.
Historically, from the 1930's to the 1950's, the rate of cardiovascular disease in high-income countries was high. Since the mid-1970's, the rate of cardiovascular disease has declined in high income countries, possibly due to socioeconomic inequalities and better management of risk factors for coronary heart disease among the wealthy.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Javier J Rodriguez-becerra, MD 400 Calle Kalaf, Pmb 59, San Juan, PR 00918-1314 Ph: (787) 854-7270 | Dr Javier J Rodriguez-becerra, MD Urb Flamboyan, Calle Mckinley I 26, Manati, PR 00674-5438 Ph: (787) 854-7270 |
News Archive
Five Prime Therapeutics, Inc. today announced it received a milestone payment from Centocor Research & Development, Inc. for the selection of a therapeutic that will be pursued for immunology-related indications. Under the collaboration, FivePrime identified multiple potential therapeutic targets through screening its comprehensive proprietary protein library in cell-based assays that were focused on therapeutic pathways underlying specific immune and inflammatory disorders.
Eli Lilly and Company today announced it will begin enrolling patients in a second Phase III study of LY450139, a gamma-secretase inhibitor being investigated as a potential treatment to delay the progression of mild to moderate Alzheimer's disease.
The new decade may herald an era of cell therapy - treating human diseases by delivering highly specific beneficial cells. In the wake of an NIH decision late last year permitting federally funded researchers to use new lines of human embryonic stem cells, the door has opened more widely to stem cell research.
In the first published nationwide survey of state Medicaid programs on "pay-for-performance" practices, more than half of all programs state that they provide financial incentives to health care providers for better quality care.
Historically, from the 1930's to the 1950's, the rate of cardiovascular disease in high-income countries was high. Since the mid-1970's, the rate of cardiovascular disease has declined in high income countries, possibly due to socioeconomic inequalities and better management of risk factors for coronary heart disease among the wealthy.
› Verified 6 days ago
Dr. Joel Santiago Martinez, MD Pathology Medicare: May Accept Medicare Assignments Practice Location: Carr #2 Km 47.7, Torre Medica 1, Edif Dr. Pedro Blanco Lugo Suite 316, Manati, PR 00674 Phone: 787-884-2445 Fax: 787-854-2636 | |
Steven Catinchi Jaime, Pathology Medicare: May Accept Medicare Assignments Practice Location: Torre Medica I Dr Pedro Blanco Lugo, 220 Carr 2, Ste 308, Manati, PR 00674 Phone: 787-884-2445 Fax: 787-854-2636 |